Inclusion Criteria:~Age 60-85 males or females~Clinically have a diagnosis of Alzheimer's disease in the
mild-moderate dementia range Mini Mental Status Examination (MMSE) between 14-24 inclusive~Must be on a stable
dose (30 days minimum) of a cholinesterase inhibitor and/or memantine (or absence thereof)~Have a reliable
co-participant who has at least 3 days of face-to-face contact per week with the patient and ensures medical
compliance with the study drug.~Neuroimaging (MRI or CT scan of the brain) should be available within 1 year of
screening~
